The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Can't miss out on their little end of day dump can they?
Oncimmune SP in March 22 was 142p now 21p. (Caveat- haven't checked for consolidations etc)
Another mouth to feed. Anyone capable of getting some cash in to the company?
I suppose it's positive that he's prepared to be associated with Valirx but let's wait and see before putting him on a pedestal.
Somebody else used to be on a pedestal and look where we are now!
Can't help a gut feeling that there's a lot going on behind the scenes but not necessarily to the advantage of the bulk of the shareholders.
Obviously and understandably, the major shareholders will want to protect their investment.
Bas, you can't be serious in holding up the "staged farce" that is Dragons Den as a benchmark for good lending decisions! The experts rarely ask pertinent questions as most of the losers that get on the show couldn't tie their own shoelaces without specialist help.
But there is a reason isn't there?
Sentiment is shot and confidence on the floor.
201 dead in the water.
No income.
No idea.
Vanity company.
No continuity of posting because some snowflake has removed my post. Valirx is a crock of merde, badly run by incompetent fools and nobody understands the business model. You'll cheer up when the good news comes through on Sareum.
Yea, the water's turned red!
I can't believe that the major shareholders aren't getting very annoyed with the current status of this company.
How much longer before someone gives an ultimatum to the CEO?
What is she bl**dy doing atm?
Looks like a RF sale at the end of day.
On the positive side, a relatively simple business model and, IMO, a trustworthy BOD.
Contrast with the absolute shambles over at Valirx where nothing is clear.
I know many of us have holdings in both.
I think it's likely that we've been stitched up like a mailbag.
Anyone still receiving reassuring emails?
Best place for them is the junk folder.
Goes to "Smart Inv" ( There's a good name for someone who makes the following comment!)
"It would be better to stop the trials and close the company once and for all."
Good point.
RF is the elephant in the room. The finance agreement is complicated and most holders (including me) don't fully understand it. It's that uncertainty and whether RF will sell into a rise, which is dampening the SP IMO.
I think It costs about £500 to issue a RNS.
That's more than the company has earned in 15 years!
Can't argue with that summary. It's just another AIM lifestyle company. Boffins who couldn't run a whelk stall in the real world.
No mention of any income.
PM's got a new God to worship!
A2, I think you're on the Bollinger.
Could this be the best RNS that Valirx has ever issued!!😅😅😅
Hope that has ruined Dillys weekend.
She'll be claiming Universal Credit soon with a bit of luck.